Loading Events
  • This event has passed.

European Pre-filled Syringes Summit

Date: 7th September 2016 - 8th September 2016 Location: London - UK

ACI’s European Prefilled Syringes Summit will be taking place in London, UK, on the 7th – 8th September, 2016. The two day event will provide an exclusive platform for collaboration and discussion between a variety of industry perspectives including manufacturers, suppliers, academia and regulators homing in on the latest opportunities arising from new Biological Medicines. The aim is to identify potential solutions, future work programmes and productive partnerships that overcome the key regulatory challenges and facilitate minimizing risk within the supply chain promoting access to safe and effective biologicals.

Key Topics

  • Meeting Demands for Change: Change Management with Owen Mumford
  • Lessons Learned from PFS Development and prospects for future applications
  • Process and efficiency of applying the TRIZ methodology to medical device innovations – a thesis from Sanofi
  • Director Itshak Golan of Daniel & Daisy Novel Therapeutics Ltd. and Expert member for Horizon 2020 at The European Commission
  • Hear from senior clinical development manager Florence Schwazenbach from BD with expert insights on patient focused development
  • Smithers Rapra introduce the technical outlook
  • Integrating quality by design: value adding principles & challenges from Novartis
  • Exploring safety features & safety syringes while overcoming technical hurdles with Roche Pharmacueticals
  • Hear the latest initiatives from Mike Hrytsak from Regeneron Pharmacueticals
  • Hear initiatives from GSK on patient and device interaction for high dose administration
  • The latest approaches for an integrated supply chain and risk management
  • The Health & Safety Executive (HSE) advise on manufacturing and supplying pre- filled syringes with safer delivery mechanisms for the reduction of needlestick injury
  • The technical spotlight: Achieving more flexibility in manufacturing with Nipro Europe
  • Risk assessment of extractables and leachables with Ipsen

Details

Start:
7th September 2016
End:
8th September 2016
Event Category:

Contact

Venue

Amba Marble Arch
Bryanston Street
London, W1H 7EH United Kingdom
+ Google Map
Phone:
+44 (0)800 330 8523
Website:
http://www.amba-hotel.com/hotels/united_kingdom/london/marble-arch/index.html

Key Topics:

  • Meeting Demands for Change: Change Management with Owen Mumford
  • Lessons Learned from PFS Development and prospects for future applications with Itshak Golan, Project Evaluator, The European Commission
  • “Process and efficiency of applying the TRIZ methodology to medical device innovations” with Sanofi 
  • Hear from senior clinical development manager Florence Schwazenbach from BD with expert insights on patient focused development
  • Integrating quality by design: value adding principles & challenges from Novartis
  • Exploring safety features & safety syringes while overcoming technical hurdles with Roche Pharmacueticals
  • Hear the latest initiatives from Mike Hrytsak from Regeneron Pharmacueticals
  • The latest approaches for an integrated supply chain and risk management
  • Development of large volume prefilled syringes

 

Senior management within:

  • Head of Device Development
  • Head of Global Product Management
  • Head of Human Factors
  • Senior Application Specialists
  • Senior Packaging Engineers
  • Manager, Finished Products and Medical Devices
  • Head of Device and Delivery Injectables
  • Senior Director, Packaging
  • Head of Medical Devices and Finished Products
  • Confirmed Speakers Include:

    Florence Schwarzenbach, Senior Clinical Development Manager,  Becton Dickinson (BD)

    Hadj Latreche, Combination Products (Medical Device & Drug) Methods, Process and Infrastructure Group Leader, Roche Pharmaceuticals

    Dr. Rene Dathe, Project Manager Medical Devices, Sanofi     

    Thomas Fischer, Senior Quality Manager Medical Device, Novartis

    Mike Hrytsak, Manager, Combination Products Regulatory Affairs, Regeneron Pharmaceuticals

    Ian Thompson, Vice President Business Development, Ypsomed AG

    Janine Jamieson, Former Assessor, MHRA

    Fabien Roy, Senior Associate, Hogan Lovells

    Martin Murphy, Marketing Lead MedTech Division, Cambridge Consultants

    Andy Varde, Director of Research & Development, Owen Mumford

    David Blakey, Device Engineering Manager, GSK

    Joel Richard, Senior Vice President, Peptides – Head Of CMC Development, IPSEN Pharmacueticals

    Bastiaan Deleeuw, Head of Business Development, Oval Medical Technologies

    Matteo Falgari, Head of Business Development , Nipro Europe

    Jeremy Kooyman, Medical Device Design & Development, Cambridge Design Partnership

    Patrick Radermacher, Managing DirectorSterisys Sàrl

    Adrian TisserandGlobal Category ManagerNemera

    Emmie Galilee, Head of Health & Social Care Services Unit, HSE Health And Safety Executive

    Dawn Smith, HM Principal Specialist Inspector (Occupational Health), HSE Health And Safety Executive

 

If you would like to be considered as a speaker for the event with a 20-45 minute presentation, please submit an abstract for consideration to:


Chloe Wates

Tel: +44 (0)20 3141 0638

Email: cwates@acieu.net

Nemera pantone 1655 C QUADRI

Nemera is a world leader in the design, development and manufacturing of drug delivery solutions for pharmaceutical, biotechnology and generics industries.

Its expertise covers several modes of delivery:

  • parenteral (auto-injectors, pens, safety devices & implanters)
  • ophthalmic (multidose, preservative-free eyedroppers)
  • nasal, buccal, auricular (pumps, valves and actuators for sprays)
  • pulmonary (pMDIs, DPIs)
  • dermal, transdermal (airless and atmospheric dispensers)

Nemera leverages decades of manufacturing and development experience in the parenteral device segment to offer patients premium products and customers a complete service. With the support of Nemera’s global centre of expertise which is composed of more than 50 engineers and experts in creative design and human factor activities, Nemera is able to drive an idea from concept all the way to high scale manufacturing.

Nemera’s balanced business model includes: full proprietary product development (such as passive safety device for prefilled syringes Safe’n’Sound®), contract manufacturing and customized solutions. This model gives flexibility to customers, being able to enter in the development and manufacturing process at any stage. Depending on their needs, pharmaceutical companies can leverage Nemera’s know-how and expertise to develop customized solutions based on either customers’ or Nemera’s intellectual property.

For more information, please visit http://www.nemera.net

Contact: information@nemera.net

LinkedIn: https://www.linkedin.com/company/nemera

Twitter: @Nemera_devices



logo_sterisys_cmyk_300dpi

STERISYS is a young and dynamic company offering an outstanding solution portfolio in two different domains: Industrial Sterilisation Equipment and Automatic Handling Systems for Pre-filled Syringes.

STERISYS is European market leader in the area of industrial sterilisation with their leading technology and advanced solutions designed for the medical devices producers and contract sterilisation organisations. STERISYS is not a mere manufacturer but a systems integrator supplying turnkey solutions. Their holistic approach towards sterilisation systems is what differentiates them from other players in the industry.

In the industrial pharmaceutical sector, STERISYS develops, markets and supplies Krysalid®, an innovative solution to resolve the problems encountered with handling, transfer and transport of nest-and-tub pre-fillable syringes.

The Krysalid® system does not focus on a specific application for automation, but in finding a global solution to handle nest-and-tub configured products. Pre-fillable systems are usually very difficult and tedious to handle manually. They are applied in multiple situations (transfer to working stations, inspection machines, terminal sterilisers, etc.) and have slightly different shapes depending on the manufacturer. The solution to all these variables is based on combining the nest-and-tub support elements with specific patented devices to facilitate the interface with both humans and robots. By using these devices, the handling operation is gentle and the products (syringes, vials) will be safe from risk.

The emergence of a new player like STERISYS in the Pre-Filled Syringes domain, in close cooperation with the syringe manufacturers, drug manufacturers and equipment suppliers, will offer a world of new possibilities to achieve the growth expectations within this industry.

www.sterisys.eu

 


ACI has put together a range of packages to suit your requirements. These range from branding options, to full scale partner solutions and can be tailored to meet your objectives and budgets.

If you are launching a new product or service and wish to gain visibility and brand recognition within your industry, contact us today!

For commercial opportunities, please contact:


Tim Rowley-Evans

+44 20 3141 0637

trowleyevans@acieu.net

IPI-logo

IPI – International Pharmaceutical Industry

IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.

We have established a strong presence in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forward in areas of Research and Development, Trials, Manufacturing and Technology Transfer.

http://www.ipimedia.com/


 

Medical News Today Logo 2016

Medical News Today is the largest independent medical and health news site on the web – with 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


Swiss Biotech copy

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ – the global brand for the industry.

http://www.swissbiotech.org/


 

Gate2Biotech

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology.

Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad.

http://www.gate2biotech.com/


pharmavision_logo (Conference)

PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. We develop market models to forecast the potential growth of key developmental products and technologies and assess the challenges and opportunities which surround this specialist sector. We will also undertake in-depth interviews with key opinion leaders and generate slide decks for conferences and corporate meetings. For further information visit our website www.pharmavision.co.uk or contact Cheryl on +44 (0) 1243 785496 or via email Info@pharmavision.co.uk


 

CBSALOGO

Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio  and mobile digital health companies, research and academic institutions and service providers.

Link: http://www.cobioscience.com/


 

TN_Hi-res_Dark

Technology Networks has been established for over 10 years and is now the leading provider of free information services for life science professionals. This includes news, events, posters, videos, webcasts, application notes, new products, a literature search engine and product directories.  The information is specifically tailored to over 30 individual communities with specific interests, all of which can be accessed through TechnologyNetworks.com.

http://www.technologynetworks.com/


Bentham-Logo-Banner

Bentham Science Publishers is rendering a vital service in the quality publication of over 100 peer-reviewed print and online scientific, technical and medical journals. These titles are indexed in recognized indexing agencies, such as Science Citation Index®, Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE etc. Some of the high impact titles which enjoy a wide reach and distribution are Current Gene Therapy (Impact Factor 4.906), Current Alzheimer Research (Impact Factor 3.796), Current Medicinal Chemistry (Impact Factor 3.715), and other popular titles.

Bentham has an extensive library of eBooks in the areas of science, technology, medicine, social sciences and humanities. Bentham eBooks publishes monographs, handbooks, conference proceedings, textbooks, review volumes, biographies and autobiographies.

www.benthamscience.com


FarmavitaR+logo

FarmavitaR+ is the professional network of  regulatory affairs  consultants. The company profiled itself to be the top service provider in  regulatory affairs, in central-east and south-east Europe. We are employing a few people in Croatia and the network of associates in Czech R, Slovak R., Hungary, Serbia, Bosnia and Herzegovina, Macedonia, Bulgaria, Romania and Turkey.


Web Packaging

Webpackaging, part of the Webpac Digital Media Group’s suite of online services, is the best global platform available for connecting packaging buyers with packaging suppliers. It is the packaging industry’s most powerful search engine scanning news, products, specifications, web sites, documents, videos, and more. The site contains 10,000+ comprehensive company portals with over one million pages of tagged content and features the 3D Design Studio, Packaging Catalogs, Packaging Maps, Packaging Trends and Innovations, Packaging Events, and more.

Webpackaging is where successful brands source packaging.

http://www.webpackaging.com/ 


 

SelectScience - European Prefilled Syringes Summit

SelectScience is an independent, online review resource for the worldwide scientific community, and the fastest way to impartial, expert opinion about the latest laboratory equipment and techniques. Discover new technologies, products and trusted reviews; plus videos, application notes and the latest science news from around the world. Become a member for free today: http://www.selectscience.net/


Markets and Markets Banner
MarketsandMarkets is a global market research organization which is also into advisory and consulting services. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

Using effective technology to automate management of large and complex data for forecasts, we provide global analysis, data and insights through unique & in-depth research, serving multi-client reports, company profiles, databases, and custom research services. These intelligence databases comprises of about 60000 reports a year, which forms one of the world’s largest intelligence resources. M&M plans to launch industry-wise and country wise market tracker for all existing research verticals.

The major industries that we cover in our market intelligence deliverables are:

Telecom & IT
Semiconductor & electronics
Chemicals
Medical Devices
Pharmaceuticals
Energy and Power
Healthcare & Life sciences
Food and Beverages
Aerospace and Defense
http://www.marketsandmarkets.com


International Journal of Biomedical Engineering and Technology

European Prefilled Syringes Summit

IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


 

International Journal of Biotechnology

0963-6048_IJBT

IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.

www.inderscience.com/ijbt


International Journal of Biomedical Nanoscience and Nanotechnology

1756-0799_IJBNN

IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.

www.inderscience.com/ijbnn


International Journal of Healthcare Technology and Management

1368-2156_IJHTM

JHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.

www.inderscience.com/ijhtm


 

International Journal of Medical Engineering and Informatics

1755-0653_IJMEI

IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.

www.inderscience.com/ijmei


 

International Journal of Biomedical Nanoscience and Nanotechnology

IJNBM

IJBNN proposes and fosters discussion on scientific and technological investigations of nanomaterials in biology and medicine, with emphasis on their biomedical implications and impacts upon the biosphere. This perspective acknowledges the complexity of biomedical nanoscience and nanotechnology as an interface between the biomedical arena and the nanosystem.

www.inderscience.com/ijbnn

Agenda Download

If you would like a copy of the brochure for this conference please complete the form below and click 'submit'.
  • This field is for validation purposes and should be left unchanged.
© The Whitmore Group 2018 Find a local office | ACI | ISM | WPL | Login

ACI Chicago, USA

205 N. Michigan Ave, 

8th Floor
,
Chicago,
IL 60601


T: +1 (312) 780 0700

F: +1 (312) 780 0600
E: chicago@acius.net

ACI Milwaukee, USA

700 W.Virginia Street,

Suite 605,

Milwaukee,
WI 53204


T: +1 (414) 221 1700

F: +1 (414) 221 1900
E: milwaukee@acius.net

ACI London, UK

10 Gough Square,
London,
EC4A 3DE

T: +44 (0)20 7981 9800
F: +44 (0)20 7593 0071
E: jayme@acieu.net

ACI Poznan, Poland

Plac Wiosny Ludow 2
Poznan,
61-831
T: +48 616 46 9780
F: +44 (0)20 7593 0071
E: hubert@acieu.net
W: www.acieu.pl

ACI Pune, India

Office No. 403. 4th Floor, Amanora Chambers,
East Building, Amanora Town Centre,
Hadapsar,
Pune, 411028, India

T: +91 (0)20 6527 2807
F: +44 (0)20 7593 0071
E: ketan@acieu.net